Biochem/physiol Actions
BIQ (FG-2216) is an orally available and potent inhibitor of prolyl-hydroxylase (PHD). BIQ induces significant and reversible plasma erythropoietin (EPO) levels in vitro and in hemodialysis patients.
Packaging
5, 25 mg in glass bottle
                             
                        
                            
                                
                                    This product has met the following criteria to qualify for the following awards: